Literature DB >> 21646451

Passive immunization with a polyclonal antiserum to the hemoglobin receptor of Haemophilus ducreyi confers protection against a homologous challenge in the experimental swine model of chancroid.

Isabelle Leduc1, William G Fusco, Neelima Choudhary, Patty A Routh, Deborah M Cholon, Marcia M Hobbs, Glen W Almond, Paul E Orndorff, Christopher Elkins.   

Abstract

Haemophilus ducreyi, the etiologic agent of chancroid, has an obligate requirement for heme. Heme is acquired by H. ducreyi from its human host via TonB-dependent transporters expressed at its bacterial surface. Of 3 TonB-dependent transporters encoded in the genome of H. ducreyi, only the hemoglobin receptor, HgbA, is required to establish infection during the early stages of the experimental human model of chancroid. Active immunization with a native preparation of HgbA (nHgbA) confers complete protection in the experimental swine model of chancroid, using either Freund's or monophosphoryl lipid A as adjuvants. To determine if transfer of anti-nHgbA serum is sufficient to confer protection, a passive immunization experiment using pooled nHgbA antiserum was conducted in the experimental swine model of chancroid. Pigs receiving this pooled nHgbA antiserum were protected from a homologous, but not a heterologous, challenge. Passively transferred polyclonal antibodies elicited to nHgbA bound the surface of H. ducreyi and partially blocked hemoglobin binding by nHgbA, but were not bactericidal. Taken together, these data suggest that the humoral immune response to the HgbA vaccine is protective against an H. ducreyi infection, possibly by preventing acquisition of the essential nutrient heme.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21646451      PMCID: PMC3147553          DOI: 10.1128/IAI.00017-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Proposed second class of Haemophilus ducreyi strains show altered protein and lipooligosaccharide profiles.

Authors:  Deborah M B Post; Bradford W Gibson
Journal:  Proteomics       Date:  2007-09       Impact factor: 3.984

2.  Iron sources for Haemophilus ducreyi.

Authors:  B C Lee
Journal:  J Med Microbiol       Date:  1991-06       Impact factor: 2.472

3.  The major outer membrane protein of Haemophilus ducreyi consists of two OmpA homologs.

Authors:  J Klesney-Tait; T J Hiltke; I Maciver; S M Spinola; J D Radolf; E J Hansen
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

4.  Comparison of enzyme immunoassays for antibodies to Haemophilus ducreyi in a community outbreak of chancroid in the United States.

Authors:  C Y Chen; K J Mertz; S M Spinola; S A Morse
Journal:  J Infect Dis       Date:  1997-06       Impact factor: 5.226

5.  Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid A protects swine from a homologous but not a heterologous challenge.

Authors:  William G Fusco; Galyna Afonina; Igor Nepluev; Deborah M Cholon; Neelima Choudhary; Patricia A Routh; Glenn W Almond; Paul E Orndorff; Herman Staats; Marcia M Hobbs; Isabelle Leduc; Christopher Elkins
Journal:  Infect Immun       Date:  2010-06-28       Impact factor: 3.441

6.  Chronic cutaneous ulcers secondary to Haemophilus ducreyi infection.

Authors:  Trisha N Peel; Deepak Bhatti; Jim C De Boer; Ivan Stratov; Denis W Spelman
Journal:  Med J Aust       Date:  2010-03-15       Impact factor: 7.738

7.  Haemophilus ducreyi Outer membrane determinants, including DsrA, define two clonal populations.

Authors:  Catherine Dinitra White; Isabelle Leduc; Bonnie Olsen; Chrystina Jeter; Chavala Harris; Christopher Elkins
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

8.  Serum resistance in Haemophilus ducreyi requires outer membrane protein DsrA.

Authors:  C Elkins; K J Morrow; B Olsen
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

9.  An isogenic hemoglobin receptor-deficient mutant of Haemophilus ducreyi is attenuated in the human model of experimental infection.

Authors:  J A Al-Tawfiq; K R Fortney; B P Katz; A F Hood; C Elkins; S M Spinola
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

10.  Eradicating chancroid.

Authors:  R Steen
Journal:  Bull World Health Organ       Date:  2001-10-23       Impact factor: 9.408

View more
  6 in total

1.  The Haemophilus ducreyi trimeric autotransporter adhesin DsrA protects against an experimental infection in the swine model of chancroid.

Authors:  William G Fusco; Neelima R Choudhary; Patty A Routh; Melissa S Ventevogel; Valerie A Smith; Gary G Koch; Glen W Almond; Paul E Orndorff; Gregory D Sempowski; Isabelle Leduc
Journal:  Vaccine       Date:  2014-05-18       Impact factor: 3.641

2.  A Class I Haemophilus ducreyi Strain Containing a Class II hgbA Allele Is Partially Attenuated in Humans: Implications for HgbA Vaccine Efficacy Trials.

Authors:  Isabelle Leduc; Kate R Fortney; Diane M Janowicz; Beth Zwickl; Sheila Ellinger; Barry P Katz; Huaiying Lin; Qunfeng Dong; Stanley M Spinola
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

3.  Extracellular haem utilization by the opportunistic pathogen Pseudomonas aeruginosa and its role in virulence and pathogenesis.

Authors:  Susana Mouriño; Angela Wilks
Journal:  Adv Microb Physiol       Date:  2021-08-13       Impact factor: 3.517

4.  Mutational analysis of hemoglobin binding and heme utilization by a bacterial hemoglobin receptor.

Authors:  W G Fusco; N R Choudhary; S E Council; E J Collins; I Leduc
Journal:  J Bacteriol       Date:  2013-05-10       Impact factor: 3.490

5.  Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface.

Authors:  Melissa Samo; Neelima R Choudhary; Kristina J Riebe; Ivo Shterev; Herman F Staats; Gregory D Sempowski; Isabelle Leduc
Journal:  Vaccine       Date:  2016-01-24       Impact factor: 3.641

Review 6.  Application of TonB-Dependent Transporters in Vaccine Development of Gram-Negative Bacteria.

Authors:  Jia Wang; Kun Xiong; Qu Pan; Weifeng He; Yanguang Cong
Journal:  Front Cell Infect Microbiol       Date:  2021-01-27       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.